비교리스트

 카트 문의
시장보고서
상품코드
1515507

비바이러스성 트랜스펙션 시약 및 시스템 시장 : 유형별, 용도별, 최종사용자별, : 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Non-Viral Transfection Reagents and Systems Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 299 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

비바이러스성 트랜스펙션 시약 및 시스템 시장 규모는 2023년에 7억 8,623만 달러에 달하며, 2024-2032년 CAGR 8.2%로 확대

비바이러스성 감염 시약 및 시스템 시장 역학

임상 현장에서의 비바이러스성 감염 시약에 대한 수요가 시장 성장의 원동력이 되고 있습니다.

비바이러스성 세포주 주입은 기존 방법에 대한 유력한 대안으로, 뚜렷한 이점을 제공합니다. 이러한 장점에는 빠른 시간, 생물학적 효율성 향상, 세포 독성 감소, 더 다양한 핵산 전달 능력 등이 포함됩니다. 임상 응용에서 비바이러스성 전사 시약의 매우 중요한 역할은 그 성장의 주요 원동력입니다. 이러한 시약은 siRNA, miRNA, 치료용 단백질을 암호화하는 DNA 플라스미드 및 CRISPR/Cas9 유전체 편집 툴와 같은 치료용 핵산 전달을 용이하게 합니다. 이러한 능력은 유전질환, 암, 감염성 질환 등 다양한 질병에 대한 혁신적인 유전자 치료법을 개발할 수 있는 길을 열어줄 것입니다.

현재 상황은 첨단 비바이러스성 세포치료 시약 및 시스템 개발에 적극적인 여러 기업의 활동이 급증하고 있음을 반영합니다. 예를 들어 최근 세포치료 전문가인 바이오센트리크(BioCentriq)와 MIT의 신생기업인 카이토펜(Kytopen)은 혁신적인 세포치료제 제조 기술을 개발하기 위해 협력하고 있습니다.

비바이러스성 트랜스펙션 시약 및 시스템 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 8.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

유형별 세분화에서는 비바이러스성 트랜스펙션 시약이 2023년 가장 큰 시장 점유율을 보일 것으로 예측됩니다.

용도별로는 연구용이 2023년 주요 유형으로 나타났습니다.

최종사용자별로는 제약회사가 2023년 주요 유형이었습니다.

지역별로는 아시아태평양이 2023년 매출에서 선두를 차지했습니다.

비바이러스성 전사 시약 및 시스템 시장 - 세분화 분석 :

세계 비 바이러스성 트랜스펙션 시약 및 시스템 시장은 유형, 애플리케이션, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 세 가지로 분류됩니다 : 비 바이러스성 주입 시약, 전기 포락선 기반 주입 시스템, 기타 비 바이러스성 주입 시스템. 일렉트로포레이션은 핵산의 존재하에 세포에 전기 펄스를 가하여 세포막에 일시적인 기공을 형성하여 유전 물질이 침투할 수 있도록 하는 것입니다. 일렉트로포레이션은 높은 주입 효율로 알려져 있으며, 특히 주입이 어려운 세포나 초기 세포에 효과적입니다. 일렉트로포레이션은 일시적인 주입이나 안정적인 주입에 사용할 수 있지만, 특수한 장비와 다양한 세포종에 대한 최적화가 필요합니다.

시장은 용도에 따라 임상과 연구라는 두 가지 범주로 나뉩니다. 비 바이러스성 전달 시약에 기초한 연구는 생물학 및 생물 의학 분야의 광범위한 분야에 걸쳐 있습니다. 예를 들어 유전자 기능 연구에서 연구자들은 비 바이러스성 전달 시약을 사용하여 특정 유전자 및 조절 인자를 세포에 도입합니다. 이를 통해 유전자 발현 패턴, 조절 메커니즘 및 다양한 세포 과정에서 유전자의 역할을 연구 할 수 있습니다.

비바이러스성 트랜스펙션 시약 및 시스템 시장 - 지역적 인사이트

아시아태평양의 생명공학 및 제약 산업은 연구개발에 대한 막대한 투자로 인해 빠르게 성장하고 있습니다. 이러한 성장은 중국, 일본, 한국 등의 국가에서 특히 두드러집니다. 그 결과, 비바이러스성 트랜스펙션 시약에 대한 수요가 증가하고 있습니다. 이러한 시약은 표적 세포에 유전물질을 정확하게 전달하고 유전자 치료 및 유전자 편집 기술 개발을 지원하는 데 매우 중요합니다. 또한 유전성 질환의 유병률 증가는 이 지역의 생물 의학 연구 및 치료 발전에서 이러한 시약에 대한 수요 증가에 기여하고 있습니다. 예를 들어 파키스탄의 인구 구성은 다양하고 근친혼이 많으며, 이는 유전성 질환의 유병률 증가에 기여하고 있습니다.

비바이러스성 전사 시약 및 시스템 시장 - 경쟁 구도:

비바이러스성 트랜스펙션 시약 및 시스템 시장의 주요 기업으로는 Thermo Fisher Scientific, Bio-Rad Laboratories, Innovio Pharmaceuticals, Maxite 등이 있습니다. 각 회사는 유전자 조작 및 세포 공학 관련 연구와 치료 응용을 촉진하기 위해 고유한 기술과 전문 지식을 제공합니다. 예를 들어 MaxCyte는 1차 세포, 줄기세포, 세포주에 대한 일시적 및 안정된 세포주 주입을 위한 확장 가능한 솔루션을 제공하며, MaxCyte의 시스템은 높은 주입 효율, 확장성, 연구 및 임상 적용 가능성으로 인정받고 있습니다. 평가받고 있습니다.

BioRad Laboratories는 전기 펄스를 적용하여 세포 내에 고효율로 핵산을 도입할 수 있는 일렉트로포레이션(electroporation) 기반 세포 주입 시스템을 전문으로 하고 있습니다. Bio-Rad의 시스템은 연구 및 바이오의약품 용도에서 이식하기 어려운 세포 및 1차 세포에 널리 사용되고 있습니다.

목차

제1장 비바이러스성 트랜스펙션 시약 및 시스템 시장 개요

  • 조사 범위
  • 시장 추정년

제2장 개요

  • 시장 내역
  • 경쟁 인사이트

제3장 비바이러스성 트랜스펙션 시약 및 시스템 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 비바이러스성 트랜스펙션 시약 및 시스템 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 지도제작
  • 규제 구조 분석

제5장 비바이러스성 트랜스펙션 시약 및 시스템 시장 : COVID-19 영향 분석

  • COVID-19 이전 영향 분석
  • COVID-19 이후 영향 분석

제6장 비바이러스성 트랜스펙션 시약 및 시스템 시장 구도

  • 비바이러스성 트랜스펙션 시약 및 시스템 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 비바이러스성 트랜스펙션 시약 및 시스템 시장 - 유형별

  • 개요
    • 부문 점유율 분석
    • 비바이러스 트랜스펙션 시약
    • 일렉트로포레이션 기반 트랜스펙션 시스템
    • 기타 비바이러스성 트랜스펙션 시스템

제8장 비바이러스성 트랜스펙션 시약 및 시스템 시장 - 용도별

  • 개요
    • 부문 점유율 분석
    • 임상
    • 조사

제9장 비바이러스성 트랜스펙션 시약 및 시스템 시장 - 최종사용자별

  • 개요
    • 부문 점유율 분석
    • 학술연구
    • 제약회사
    • 기타

제10장 비바이러스성 트랜스펙션 시약 및 시스템 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 비바이러스성 트랜스펙션 시약 및 시스템 업계

  • 경쟁 대시보드
  • 기업 개요
    • Thermo Fisher Scientific(TFS)
    • Lonza Group
    • Imunon(Formerly known as Celsion)
    • Promega Corporation
    • Altogen Biosystems
    • Mirus Bio LLC
    • Genprex
    • Polyplus-Transfection SA
    • Bio-Rad Laboratories
    • MaxCyte
    • MilliporeSigma
    • Qiagen
    • Takara Bio

제12장 애널리스트의 전방위 전망

KSA 24.07.26

REPORT HIGHLIGHT

Non-Viral Transfection Reagents and Systems Market size was valued at USD 786.23 Million in 2023, expanding at a CAGR of 8.2% from 2024 to 2032.

Non-viral transfection reagents are substances used in molecular biology and biotechnology to deliver genetic material (such as DNA or RNA) into cells without the use of viral vectors. They facilitate the introduction of nucleic acids into cells for various purposes, including gene expression studies, protein production, gene therapy, and genome editing.

Non-Viral Transfection Reagents and Systems Market- Market Dynamics

The need for Non-Viral Transfection Reagents in clinical settings is fueling their market growth.

Non-viral transfection is a compelling alternative to established methods, offering distinct advantages. These advantages include expedited timelines, enhanced biological efficiency, reduced cytotoxicity, and the ability to deliver a wider variety of nucleic acids. The pivotal role of non-viral transfection reagents in clinical applications is a key driver of their growth. These reagents facilitate the delivery of therapeutic nucleic acids, such as siRNA, miRNA, and DNA plasmids encoding therapeutic proteins or CRISPR/Cas9 genome editing tools. This capability paves the way for the development of innovative gene therapies for a broad spectrum of conditions, including genetic disorders, cancers, and infectious diseases.

The current landscape reflects a surge in activity by numerous companies actively developing advanced non-viral transfection reagents and systems. For example, recently, BioCentriq, a cell therapy expert, and Kytopen, an MIT startup, teamed up to develop innovative cell therapy manufacturing technology.

Non-Viral Transfection Reagents and Systems Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2024-2032)

Based on Type segmentation, non-viral transfection reagents were predicted to show maximum market share in the year 2023

Based on Application segmentation, Research Applications was the leading type in 2023

Based on End User segmentation, Pharmaceutical Companies were the leading type in 2023

Based on region, Asia-Pacific was the leading revenue generator in 2023

Non-Viral Transfection Reagents and Systems Market- Segmentation Analysis:

The Global Non-Viral Transfection Reagents and Systems Market is segmented based on Type, Application, End User, and Region.

The market is divided into three categories based on Type: Non-Viral Transfection Reagents, Electroporation-based Transfection Systems and Other Non-Viral Transfection Systems. Electroporation involves applying electrical pulses to cells in the presence of nucleic acids, creating temporary pores in the cell membrane through which genetic material can enter. Electroporation is known for its high transfection efficiency and is particularly effective for difficult-to-transfect cells and primary cells. It can be used for transient and stable transfection but requires specialized equipment and optimization for different cell types.

The market is divided into two categories based on Application: Clinical and Research. Research based on non-viral transfection reagents spans a wide spectrum of biological and biomedical fields. Such as in gene function studies, researchers employ non-viral transfection reagents to introduce specific genes or regulatory elements into cells. This allows them to study gene expression patterns, regulatory mechanisms, and the roles of genes in various cellular processes.

Non-Viral Transfection Reagents and Systems Market- Geographical Insights

The biotechnology and pharmaceutical industries in the Asia-Pacific region are expanding swiftly due to substantial investments in research and development. This growth is particularly pronounced in countries such as China, Japan, and South Korea. As a result, there is an increasing need for non-viral transfection reagents. These reagents are crucial for delivering genetic material precisely to target cells and supporting the development of gene therapy and gene editing technologies. Moreover, the rising prevalence of genetic disorders is contributing to the heightened demand for these reagents in the region's biomedical research and therapeutic advancements. For instance, the diverse makeup of Pakistan's population, characterized by significant levels of consanguinity, contributes to the higher prevalence of genetic disorders cases.

Non-Viral Transfection Reagents and Systems Market- Competitive Landscape:

Some of the key players in the Non-Viral Transfection Reagent and Systems Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inovio Pharmaceuticals, and MaxCyte. Each brings unique technologies and expertise to advance research and therapeutic applications involving genetic manipulation and cell engineering. For example, MaxCyte, is offering scalable solutions for transient and stable transfection of primary cells, stem cells, and cell lines. MaxCyte's systems are valued for their high transfection efficiency, scalability, and applicability in research and clinical settings.

Bio-Rad Laboratories specialises in electroporation-based transfection systems, which offer high efficiency for delivering nucleic acids into cells by applying electrical pulses. Bio-Rad's systems are widely used for difficult-to-transfect cells and primary cells in research and biopharmaceutical applications.

Recent Developments:

In Sept 2023, A new enterprise stemming from the University of Nottingham, dedicated to advancing a dry powder gene therapy formulation for bone graft augmentation, along with its partner, the University of Nottingham, has been granted £995,000 by Innovate UK, the UK's innovation agency.

In August 2023, Altogen Biosystems introduced a focused reagent designed to transport biomolecules to the lungs for treating patients with pulmonary diseases. The drug has safely and effectively transported small molecules, DNA, RNA, and proteins to the lungs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific (TFS)

Lonza Group

Imunon (Formerly known as Celsion)

Promega Corporation

Altogen Biosystems

Mirus Bio LLC

Genprex

Polyplus-Transfection SA

Bio-Rad Laboratories

MaxCyte

MilliporeSigma

Qiagen

Takara Bio

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Viral Transfection Reagents
  • Electroporation-based Transfection Systems
  • Other Non-Viral Transfection Systems

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical
  • Research

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Academic and Research
  • Pharmaceutical Companies
  • Others

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-Viral Transfection Reagents and Systems Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-Viral Transfection Reagents and Systems Market Snippet by Type
    • 2.1.2. Non-Viral Transfection Reagents and Systems Market Snippet by Application
    • 2.1.3. Non-Viral Transfection Reagents and Systems Market Snippet by End User
    • 2.1.4. Non-Viral Transfection Reagents and Systems Market Snippet by Country
    • 2.1.5. Non-Viral Transfection Reagents and Systems Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-Viral Transfection Reagents and Systems Key Market Trends

  • 3.1. Non-Viral Transfection Reagents and Systems Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-Viral Transfection Reagents and Systems Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-Viral Transfection Reagents and Systems Market Opportunities
  • 3.4. Non-Viral Transfection Reagents and Systems Market Future Trends

4. Non-Viral Transfection Reagents and Systems Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-Viral Transfection Reagents and Systems Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Non-Viral Transfection Reagents and Systems Market Landscape

  • 6.1. Non-Viral Transfection Reagents and Systems Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-Viral Transfection Reagents and Systems Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Non-Viral Transfection Reagents
    • 7.1.3. Electroporation-based Transfection Systems
    • 7.1.4. Other Non-Viral Transfection Systems

8. Non-Viral Transfection Reagents and Systems Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Clinical
    • 8.1.3. Research

9. Non-Viral Transfection Reagents and Systems Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Academic and Research
    • 9.1.3. Pharmaceutical Companies
    • 9.1.4. Others

10. Non-Viral Transfection Reagents and Systems Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Non-Viral Transfection Reagents and Systems Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific (TFS)
    • 11.2.2. Lonza Group
    • 11.2.3. Imunon (Formerly known as Celsion)
    • 11.2.4. Promega Corporation
    • 11.2.5. Altogen Biosystems
    • 11.2.6. Mirus Bio LLC
    • 11.2.7. Genprex
    • 11.2.8. Polyplus-Transfection SA
    • 11.2.9. Bio-Rad Laboratories
    • 11.2.10. MaxCyte
    • 11.2.11. MilliporeSigma
    • 11.2.12. Qiagen
    • 11.2.13. Takara Bio

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제